Essix Biosciences Converts Warrants into Ind-Swift Laboratories Equity Shares
Ind-Swift Laboratories Ltd 路 Acquisition/ Disposal of Shares 路 12 Oct 2026, 11:08 pm
Essix Biosciences Converts Warrants into Ind-Swift Laboratories Equity Shares Promoter group entity Essix Biosciences acquired 14.00 lakh equity shares (Rs 10 face value) of Ind-Swift Laboratories on 8th Oct'26 through the conversion of fully convertible warrants. The acquisition represents 1.58% of pre-issue and 1.49% of diluted share capital. Post-allotment, Essix Biosciences' direct holding rose to 3.43 crore shares (38.80%), while the total promoter and PAC holding increased to 43.84% of total share capital (47.18% diluted), leaving 56.00 lakh unexercised warrants. Target company paid-up equity capital expanded to Rs 88.36 crore.
Original exchange filing (PDF)
More announcements from Ind-Swift Laboratories Ltd
- Please find enclosed transcript for earnings call held on November 04, 2026. 路 10 Nov 2026
- Audio recording of earning conference call held on 04.11.2026 on un-audited financial results for the quarter ended 30.09.2026. 路 05 Nov 2026
- Please find enclosed investor presentation on un-audited financial results for the quarter ended September 30, 2026 路 04 Nov 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 in respect of receipt of funds raised through preferential issue of 70,00,000 Fully Convertible Warrants 路 03 Nov 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 in respect of funds raised through Preferential Issue 2.6 Cr Fully Convertible Warrants 路 03 Nov 2026
- Please find enclosed Schedule of Analyst / Investor Meet which will be held on Wednesday, November 04, 2026, at 04.00 P.M. IST in respect of financial results of the Company for the quarter .... 路 04 Nov 2026
- Press Release in respect of Unaudited Financial Results (Standalone & Consolidated) for the second quarter and half year ended September 30, 2026 路 30 Oct 2026
- Please refer attached pdf 路 30 Oct 2026
